Zacks Research Increases Earnings Estimates for Lam Research

Lam Research Corporation (NASDAQ:LRCX) – Analysts at Zacks Research lifted their FY2027 EPS estimates for Lam Research in a note issued to investors on Wednesday, November 12th. Zacks Research analyst Team now anticipates that the semiconductor company will earn $4.97 per share for the year, up from their prior estimate of $4.52. Zacks Research currently has a “Strong-Buy” rating on the stock. The consensus estimate for Lam Research’s current full-year earnings is $3.71 per share.

Lam Research (NASDAQ:LRCX) last issued its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, topping analysts’ consensus estimates of $1.22 by $0.04. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The company had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.23 billion. During the same period in the previous year, the firm earned $0.86 earnings per share. Lam Research’s quarterly revenue was up 27.7% compared to the same quarter last year. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS.

A number of other equities research analysts also recently commented on the company. Wells Fargo & Company lifted their target price on Lam Research from $135.00 to $145.00 and gave the company an “equal weight” rating in a research report on Thursday, October 23rd. Deutsche Bank Aktiengesellschaft raised their price objective on Lam Research from $150.00 to $160.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Argus upped their target price on shares of Lam Research from $105.00 to $120.00 and gave the company a “buy” rating in a research report on Friday, August 1st. B. Riley increased their target price on shares of Lam Research from $160.00 to $175.00 and gave the stock a “buy” rating in a research note on Monday, October 20th. Finally, Berenberg Bank boosted their price target on shares of Lam Research from $122.00 to $165.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. One research analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat, Lam Research presently has a consensus rating of “Moderate Buy” and an average price target of $149.04.

Lam Research Trading Down 1.4%

Shares of LRCX stock traded down $2.22 during trading on Friday, hitting $151.10. 7,317,011 shares of the stock traded hands, compared to its average volume of 11,815,612. Lam Research has a 52-week low of $56.32 and a 52-week high of $167.15. The firm has a market capitalization of $189.79 billion, a P/E ratio of 33.31, a price-to-earnings-growth ratio of 1.68 and a beta of 1.87. The firm’s fifty day moving average price is $139.84 and its 200-day moving average price is $108.87. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.21 and a quick ratio of 1.60.

Institutional Investors Weigh In On Lam Research

A number of hedge funds have recently bought and sold shares of the stock. IMG Wealth Management Inc. purchased a new stake in Lam Research during the 2nd quarter worth about $26,000. Howard Hughes Medical Institute acquired a new stake in shares of Lam Research during the second quarter worth about $27,000. Strategic Wealth Investment Group LLC purchased a new stake in shares of Lam Research in the 2nd quarter valued at about $29,000. Delos Wealth Advisors LLC acquired a new stake in shares of Lam Research in the 2nd quarter valued at about $30,000. Finally, REAP Financial Group LLC acquired a new stake in shares of Lam Research in the 2nd quarter valued at about $31,000. Institutional investors and hedge funds own 84.61% of the company’s stock.

Insider Buying and Selling

In other Lam Research news, Director Bethany Mayer sold 1,298 shares of the stock in a transaction that occurred on Monday, November 3rd. The shares were sold at an average price of $159.99, for a total transaction of $207,667.02. Following the sale, the director directly owned 1,652 shares in the company, valued at $264,303.48. This represents a 44.00% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Vahid Vahedi sold 52,190 shares of the firm’s stock in a transaction that occurred on Monday, October 13th. The shares were sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the completion of the transaction, the senior vice president directly owned 251,047 shares of the company’s stock, valued at $34,870,428.30. This represents a 17.21% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 62,528 shares of company stock valued at $8,880,448 in the last ninety days. Company insiders own 0.31% of the company’s stock.

Lam Research Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd will be issued a $0.26 dividend. The ex-dividend date is Wednesday, December 3rd. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.7%. Lam Research’s payout ratio is 22.91%.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.